Earnings Call · Q3 FY2021·2021-11-10

Q3 21EPS -5.41%·Rev n/aQ2 21EPS -36.67%·Rev n/aQ1 21EPS +11.76%·Rev n/aQ4 20EPS -7.89%·Rev n/a⚠ consensus missing

Xeris Biopharma Holdings, Inc. XERS

Allison Wey — Senior Vice President of Investor Relations and Corporate Communications

Paul Edick — Chief Executive Officer

Steve Pieper — Chief Financial Officer

−3.1%1d on move date−2.3% vs SPY3d+9.2%5d+21.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more XERS calls or request research access.

More XERS calls Browse calls Request research access